{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T01:52:07Z","timestamp":1784253127484,"version":"3.55.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["3\/2\/2\/85\/2022-NCD-III"],"award-info":[{"award-number":["3\/2\/2\/85\/2022-NCD-III"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s00210-026-04999-2","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T03:18:44Z","timestamp":1769743124000},"page":"10163-10184","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Preclinical evaluation of gefitinib and betulin-loaded surface functionalized liposomes for the treatment of hepatocellular carcinoma via asialoglycoprotein receptor targeting"],"prefix":"10.1007","volume":"399","author":[{"given":"Amita","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vipin","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Km","family":"Prachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Rajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijayakumar Mahalingam","family":"Rajamanickam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"issue":"1","key":"4999_CR1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1749-6632.2009.04911.x","volume":"1171","author":"BB Aggarwal","year":"2009","unstructured":"Aggarwal BB, Kunnumakkara AB, Harikumar KB, Gupta SR, Tharakan ST, Koca C, Dey S, Sung B (2009) Signal transducer and activator of transcription-3, inflammation, and cancer. Ann N Y Acad Sci 1171(1):59\u201376. https:\/\/doi.org\/10.1111\/j.1749-6632.2009.04911.x","journal-title":"Ann N Y Acad Sci"},{"key":"4999_CR2","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.4314\/tjpr.v19i10.1","volume":"19","author":"Y Alkhateeb","year":"2020","unstructured":"Alkhateeb Y, Jarrar QB, Abas F, Rukayadi Y, Shaari K (2020) Characterization, purity assessment, and preparation of liposomal formulation of 2,4,6-trihydroxygeranylacetophenone. Trop J Pharm Res 19:2025\u20132032","journal-title":"Trop J Pharm Res"},{"key":"4999_CR3","unstructured":"Alkhatib MH, Nori DA, Al-Ghamdi MA (2017) Antitumor activity and hepatotoxicity effect of sorafenib incorporated into nanoemulsion formulated with flaxseed oil. Int J Pharm Res Allied Sci 6:175\u201388"},{"key":"4999_CR4","doi-asserted-by":"publisher","first-page":"564","DOI":"10.12991\/marupj.319304","volume":"21","author":"S Arefin","year":"2017","unstructured":"Arefin S, Hossain M, Neshe S, Rashid MM, Amin M, Hussain M (2017) Tartrazine induced changes in physiological and biochemical parameters in Swiss albino mice, Mus musculus. Marmara Pharm J 21:564\u2013564. https:\/\/doi.org\/10.12991\/marupj.319304","journal-title":"Marmara Pharm J"},{"issue":"5","key":"4999_CR5","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1159\/000514356","volume":"39","author":"S Atta","year":"2021","unstructured":"Atta S, Kamel M, Mansour W, Hussein T, Maher K, Elrefaiy MA (2021) Ascitic fluid cytokines in chronic liver disease: a possible prognostic tool. Dig Dis 39(5):534\u2013539. https:\/\/doi.org\/10.1159\/000514356","journal-title":"Dig Dis"},{"issue":"2","key":"4999_CR6","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1309\/wf10qaaed3pp93bh","volume":"129","author":"AF Buckley","year":"2008","unstructured":"Buckley AF, Burgart LJ, Sahai V, Kakar S (2008) Epidermal growth factor receptor expression and gene copy number in conventional hepatocellular carcinoma. Am J Clin Pathol 129(2):245\u2013251. https:\/\/doi.org\/10.1309\/wf10qaaed3pp93bh","journal-title":"Am J Clin Pathol"},{"key":"4999_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1565692","volume":"15","author":"L Cano","year":"2025","unstructured":"Cano L, Foucher F, Musso O (2025) Geographic diversity of human liver cancers mirrors global social inequalities. Front Oncol 15:1565692. https:\/\/doi.org\/10.3389\/fonc.2025.1565692","journal-title":"Front Oncol"},{"issue":"2","key":"4999_CR8","doi-asserted-by":"publisher","DOI":"10.11613\/bm.2025.020501","volume":"35","author":"I \u010cepelak","year":"2025","unstructured":"\u010cepelak I, Dodig S, Pavi\u0107 I (2025) Bilirubin - new insights into an old molecule. Biochem Med (Zagreb) 35(2):020501. https:\/\/doi.org\/10.11613\/bm.2025.020501","journal-title":"Biochem Med (Zagreb)"},{"key":"4999_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.acr.2020.10.001","volume":"149","author":"S Chidambaranathan-Reghupaty","year":"2021","unstructured":"Chidambaranathan-Reghupaty S, Fisher PB, Sarkar D (2021) Hepatocellular carcinoma (HCC): epidemiology, etiology and molecular classification. Adv Cancer Res 149:1\u201361. https:\/\/doi.org\/10.1016\/bs.acr.2020.10.001","journal-title":"Adv Cancer Res"},{"key":"4999_CR10","doi-asserted-by":"publisher","unstructured":"De Lorenzo S, Tovoli F, Trevisani F (2022) Mechanisms of primary and acquired resistance to immune checkpoint inhibitors in patients with hepatocellular carcinoma. Cancers 14(19):4616.https:\/\/doi.org\/10.3390\/cancers14194616","DOI":"10.3390\/cancers14194616"},{"issue":"6","key":"4999_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107351","volume":"300","author":"Y Fan","year":"2024","unstructured":"Fan Y, Zhang R, Wang C, Pan M, Geng F, Zhong Y, Su H, Kou Y, Mo X, Lefai E, Han X, Chakravarti A, Guo D (2024) STAT3 activation of SCAP-SREBP-1 signaling upregulates fatty acid synthesis to promote tumor growth. J Biol Chem 300(6):107351. https:\/\/doi.org\/10.1016\/j.jbc.2024.107351","journal-title":"J Biol Chem"},{"key":"4999_CR12","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/939523","volume":"2015","author":"MC Ferraz","year":"2015","unstructured":"Ferraz MC, de Oliveira JL, de Oliveira Junior JR, Cogo JC, Dos Santos MG, Franco LM, Puebla P, Ferraz HO, Ferraz HG, da Rocha MM, Hyslop S, San Feliciano A, Oshima-Franco Y (2015) The triterpenoid betulin protects against the neuromuscular effects of bothrops jararacussu snake venom in vivo. Evid Based Complement Alternat Med 2015:939523. https:\/\/doi.org\/10.1155\/2015\/939523","journal-title":"Evid Based Complement Alternat Med"},{"key":"4999_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112813","volume":"140","author":"AK Gautam","year":"2024","unstructured":"Gautam AK, Kumar P, Kumar V, Singh A, Mahata T, Maity B, Yadav S, Kumar D, Singh S, Saha S, Vijayakumar MR (2024) Preclinical evaluation of dalbergin loaded PLGA-galactose-modified nanoparticles against hepatocellular carcinoma via inhibition of the AKT\/NF-\u03baB signaling pathway. Int Immunopharmacol 140:112813. https:\/\/doi.org\/10.1016\/j.intimp.2024.112813","journal-title":"Int Immunopharmacol"},{"issue":"11","key":"4999_CR14","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1038\/sj.bjc.6602231","volume":"91","author":"G Giannelli","year":"2004","unstructured":"Giannelli G, Azzariti A, Fransvea E, Porcelli L, Antonaci S, Paradiso A (2004) Laminin-5 offsets the efficacy of gefitinib (\u2019Iressa\u2019) in hepatocellular carcinoma cells. Br J Cancer 91(11):1964\u20131969. https:\/\/doi.org\/10.1038\/sj.bjc.6602231","journal-title":"Br J Cancer"},{"issue":"6","key":"4999_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2024.101447","volume":"14","author":"S Giri","year":"2024","unstructured":"Giri S, Singh A (2024) Epidemiology of hepatocellular carcinoma in India - an updated review for 2024. J Clin Exp Hepatol 14(6):101447. https:\/\/doi.org\/10.1016\/j.jceh.2024.101447","journal-title":"J Clin Exp Hepatol"},{"issue":"4","key":"4999_CR16","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1049\/nbt2.12028","volume":"15","author":"VMB Grace","year":"2021","unstructured":"Grace VMB, Wilson DD, Guruvayoorappan C, Danisha JP, Bonati L (2021) Liposome nano-formulation with cationic polar lipid DOTAP and cholesterol as a suitable pH-responsive carrier for molecular therapeutic drug (all-trans retinoic acid) delivery to lung cancer cells. IET Nanobiotechnol 15(4):380\u2013390. https:\/\/doi.org\/10.1049\/nbt2.12028","journal-title":"IET Nanobiotechnol"},{"issue":"6","key":"4999_CR17","doi-asserted-by":"publisher","first-page":"673","DOI":"10.2217\/nnm.16.5","volume":"11","author":"N Hoshyar","year":"2016","unstructured":"Hoshyar N, Gray S, Han H, Bao G (2016) The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction. Nanomedicine (Lond) 11(6):673\u2013692. https:\/\/doi.org\/10.2217\/nnm.16.5","journal-title":"Nanomedicine (Lond)"},{"key":"4999_CR18","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1006\/bbrc.2001.5139","volume":"285","author":"H Ise","year":"2001","unstructured":"Ise H, Sugihara N, Negishi N, Nikaido T, Akaike T (2001) Low asialoglycoprotein receptor expression as markers for highly proliferative potential hepatocytes. Biochem Biophys Res Commun 285:172\u2013182. https:\/\/doi.org\/10.1006\/bbrc.2001.5139","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"4999_CR19","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3109\/08982100903347923","volume":"20","author":"C Jaafar-Maalej","year":"2010","unstructured":"Jaafar-Maalej C, Diab R, Andrieu V, Elaissari A, Fessi H (2010) Ethanol injection method for hydrophilic and lipophilic drug-loaded liposome preparation. J Liposome Res 20(3):228\u2013243. https:\/\/doi.org\/10.3109\/08982100903347923","journal-title":"J Liposome Res"},{"key":"4999_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120511","volume":"600","author":"R John","year":"2021","unstructured":"John R, Dalal B, Shankarkumar A, Devarajan PV (2021) Innovative betulin nanosuspension exhibits enhanced anticancer activity in a triple negative breast cancer cell line and zebrafish angiogenesis model. Int J Pharm 600:120511. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120511","journal-title":"Int J Pharm"},{"key":"4999_CR21","doi-asserted-by":"publisher","first-page":"92","DOI":"10.25259\/IJMIO_5_2020","volume":"5","author":"A Kandasamy","year":"2020","unstructured":"Kandasamy A, Pottakkat B (2020) Alpha-fetoprotein: a molecular bootstrap for hepatocellular carcinoma. Int J Mol Immun Onco 5:92\u201395. https:\/\/doi.org\/10.25259\/IJMIO_5_2020","journal-title":"Int J Mol Immun Onco"},{"key":"4999_CR22","doi-asserted-by":"publisher","DOI":"10.3332\/ecancer.2024.1760","volume":"18","author":"S Kannusamy","year":"2024","unstructured":"Kannusamy S, Oak A, Cheulkar S, Maske K, Dashmukhe E, Patil A, Morajkar M, Sengar M, Balasubramaniam G, Dikshit R (2024) Spectrum of hepatitis B and hepatitis C-related cancers in India. Ecancermedicalscience 18:1760. https:\/\/doi.org\/10.3332\/ecancer.2024.1760","journal-title":"Ecancermedicalscience"},{"key":"4999_CR23","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/165214","volume":"2011","author":"T Kosaka","year":"2011","unstructured":"Kosaka T, Yamaki E, Mogi A, Kuwano H (2011) Mechanisms of resistance to EGFR TKIs and development of a new generation of drugs in non-small-cell lung cancer. J Biomed Biotechnol 2011:165214. https:\/\/doi.org\/10.1155\/2011\/165214","journal-title":"J Biomed Biotechnol"},{"key":"4999_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2019.104489","volume":"109","author":"P Kumar","year":"2019","unstructured":"Kumar P, Agarwal A, Singh AK, Gautam AK, Chakraborti S, Kumar U, Kumar D, Bhattacharya B, Panda P, Saha B, Qidwai T, Maity B, Saha S (2019) Antineoplastic properties of zafirlukast against hepatocellular carcinoma via activation of mitochondrial mediated apoptosis. Regul Toxicol Pharmacol 109:104489. https:\/\/doi.org\/10.1016\/j.yrtph.2019.104489","journal-title":"Regul Toxicol Pharmacol"},{"key":"4999_CR25","doi-asserted-by":"publisher","DOI":"10.1177\/09603271211073593","volume":"41","author":"A Kumar","year":"2022","unstructured":"Kumar A, Naithani M, Kumar N, Singh N, Agrawal S, Sharma A, Thapliyal S, Singh J, Handu S (2022) Piperlongumine inhibits diethylnitrosamine induced hepatocellular carcinoma in rats. Hum Exp Toxicol 41:9603271211073593. https:\/\/doi.org\/10.1177\/09603271211073593","journal-title":"Hum Exp Toxicol"},{"key":"4999_CR26","doi-asserted-by":"publisher","unstructured":"Kushwaha P, Raj V, Singh A, Keshari A, Saraf S, Mandal S, Yadav R, Saha S (2015) Antidiabetic effects of isolated sterols from Ficus racemosa leaves. RSC Adv 5. https:\/\/doi.org\/10.1039\/C5RA00790A","DOI":"10.1039\/C5RA00790A"},{"issue":"4","key":"4999_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0096185","volume":"9","author":"J Li","year":"2014","unstructured":"Li J, Chen L, Zhang X, Zhang Y, Liu H, Sun B, Zhao L, Ge N, Qian H, Yang Y, Wu M, Yin Z (2014) Detection of circulating tumor cells in hepatocellular carcinoma using antibodies against asialoglycoprotein receptor, carbamoyl phosphate synthetase 1 and pan-cytokeratin. PLoS ONE 9(4):e96185. https:\/\/doi.org\/10.1371\/journal.pone.0096185","journal-title":"PLoS ONE"},{"issue":"32","key":"4999_CR28","doi-asserted-by":"publisher","first-page":"52392","DOI":"10.18632\/oncotarget.10721","volume":"7","author":"J Li","year":"2016","unstructured":"Li J, Yan H, Zhao L, Jia W, Yang H, Liu L, Zhou X, Miao P, Sun X, Song S, Zhao X, Liu J, Huang G (2016) Inhibition of SREBP increases gefitinib sensitivity in non-small cell lung cancer cells. Oncotarget 7(32):52392\u201352403. https:\/\/doi.org\/10.18632\/oncotarget.10721","journal-title":"Oncotarget"},{"key":"4999_CR29","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.5897\/AJPP2013.3517","volume":"7","author":"L Lodhi","year":"2013","unstructured":"Lodhi L (2013) Evaluation of mechanism of hepatotoxicity of leflunomide using albino wistar rats. Afr J Pharm Pharmacol 7:1625\u20131631. https:\/\/doi.org\/10.5897\/AJPP2013.3517","journal-title":"Afr J Pharm Pharmacol"},{"issue":"1\u20132","key":"4999_CR30","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/s0168-3659(99)00248-5","volume":"65","author":"H Maeda","year":"2000","unstructured":"Maeda H, Wu J, Sawa T, Matsumura Y, Hori K (2000) Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 65(1\u20132):271\u2013284. https:\/\/doi.org\/10.1016\/s0168-3659(99)00248-5","journal-title":"J Control Release"},{"issue":"Pt 1","key":"4999_CR31","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1042\/0264-6021:3480113","volume":"348","author":"D McAbee","year":"2000","unstructured":"McAbee D, Jiang X, Walsh K (2000) Lactoferrin binding to the rat asialoglycoprotein receptor requires the receptor\u2019s lectin properties. Biochem J 348(Pt 1):113\u2013117. https:\/\/doi.org\/10.1042\/0264-6021:3480113","journal-title":"Biochem J"},{"issue":"1","key":"4999_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-26085-2","volume":"12","author":"A Miatmoko","year":"2022","unstructured":"Miatmoko A, Faradisa AA, Jauhari AA, Hariawan BS, Cahyani DM, Plumeriastuti H, Sari R, Hendradi E (2022) The effectiveness of ursolic acid niosomes with chitosan coating for prevention of liver damage in mice induced by n-nitrosodiethylamine. Sci Rep 12(1):21397. https:\/\/doi.org\/10.1038\/s41598-022-26085-2","journal-title":"Sci Rep"},{"issue":"1","key":"4999_CR33","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/S1665-2681(19)32034-4","volume":"5","author":"D Motola-Kuba","year":"2006","unstructured":"Motola-Kuba D, Zamora-Vald\u00e9s D, Uribe M, M\u00e9ndez-S\u00e1nchez N (2006) Hepatocellular carcinoma. An overview. Ann Hepatol 5(1):16\u201324","journal-title":"Ann Hepatol"},{"key":"4999_CR34","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.ejphar.2013.11.022","volume":"723","author":"M Nasr","year":"2014","unstructured":"Nasr M, Selima E, Hamed O, Kazem A (2014) Targeting different angiogenic pathways with combination of curcumin, leflunomide and perindopril inhibits diethylnitrosamine-induced hepatocellular carcinoma in mice. Eur J Pharmacol 723:267\u2013275. https:\/\/doi.org\/10.1016\/j.ejphar.2013.11.022","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"4999_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03335-7","volume":"12","author":"T Noguchi","year":"2021","unstructured":"Noguchi T, Sekiguchi Y, Kudoh Y, Naganuma R, Kagi T, Nishidate A, Maeda K, Ishii C, Toyama T, Hirata Y, Hwang GW, Matsuzawa A (2021) Gefitinib initiates sterile inflammation by promoting IL-1\u03b2 and HMGB1 release via two distinct mechanisms. Cell Death Dis 12(1):49. https:\/\/doi.org\/10.1038\/s41419-020-03335-7","journal-title":"Cell Death Dis"},{"key":"4999_CR36","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.cca.2013.04.009","volume":"423","author":"MJ Oliveira","year":"2013","unstructured":"Oliveira MJ, van Deventer HE, Bachmann LM, Warnick GR, Nakajima K, Nakamura M, Sakurabayashi I, Kimberly MM, Shamburek RD, Korzun WJ, Myers GL, Miller WG, Remaley AT (2013) Evaluation of four different equations for calculating LDL-C with eight different direct HDL-C assays. Clin Chim Acta 423:135\u2013140. https:\/\/doi.org\/10.1016\/j.cca.2013.04.009","journal-title":"Clin Chim Acta"},{"issue":"5","key":"4999_CR37","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1101\/gad.276733.115","volume":"30","author":"M Petruzzelli","year":"2016","unstructured":"Petruzzelli M, Wagner EF (2016) Mechanisms of metabolic dysfunction in cancer-associated cachexia. Genes Dev 30(5):489\u2013501. https:\/\/doi.org\/10.1101\/gad.276733.115","journal-title":"Genes Dev"},{"issue":"2","key":"4999_CR38","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s13318-016-0340-7","volume":"42","author":"ON Pozharitskaya","year":"2017","unstructured":"Pozharitskaya ON, Karlina MV, Shikov AN, Kosman VM, Makarov VG, Casals E, Rosenholm JM (2017) Pharmacokinetics and tissue disposition of nanosystem-entrapped betulin after endotracheal administration to rats. Eur J Drug Metab Pharmacokinet 42(2):327\u2013332. https:\/\/doi.org\/10.1007\/s13318-016-0340-7","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"4999_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17101618","author":"S Ribback","year":"2016","unstructured":"Ribback S, Sailer V, B\u00f6hning E, G\u00fcnther J, Merz J, Steinm\u00fcller F, Utpatel K, Cigliano A, Peters K, Pilo MG, Evert M, Calvisi DF, Dombrowski F (2016) The epidermal growth factor receptor (EGFR) inhibitor gefitinib reduces but does not prevent tumorigenesis in chemical and hormonal induced hepatocarcinogenesis rat models. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms17101618","journal-title":"Int J Mol Sci"},{"key":"4999_CR40","doi-asserted-by":"publisher","first-page":"557","DOI":"10.2147\/ijn.S14615","volume":"6","author":"B Ruozi","year":"2011","unstructured":"Ruozi B, Belletti D, Tombesi A, Tosi G, Bondioli L, Forni F, Vandelli MA (2011) AFM, ESEM, TEM, and CLSM in liposomal characterization: a comparative study. Int J Nanomedicine 6:557\u2013563. https:\/\/doi.org\/10.2147\/ijn.S14615","journal-title":"Int J Nanomedicine"},{"issue":"1-3","key":"4999_CR41","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ejphar.2012.09.021","volume":"697","author":"S Saha","year":"2012","unstructured":"Saha S, Chan DS, Lee CY, Wong W, New LS, Chui WK, Yap CW, Chan EC, Ho HK (2012) Pyrrolidinediones reduce the toxicity of thiazolidinediones and modify their anti-diabetic and anti-cancer properties. Eur J Pharmacol 697(1\u20133):13\u201323. https:\/\/doi.org\/10.1016\/j.ejphar.2012.09.021","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"4999_CR42","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3390\/pharmaceutics10030151","volume":"10","author":"M Sarfraz","year":"2018","unstructured":"Sarfraz M, Afzal A, Yang T, Gai Y, Raza SM, Khan MW, Cheng Y, Ma X, Xiang G (2018) Development of dual drug loaded nanosized liposomal formulation by a reengineered ethanolic injection method and its pre-clinical pharmacokinetic studies. Pharmaceutics 10(3):151","journal-title":"Pharmaceutics"},{"issue":"2","key":"4999_CR43","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/hep.20538","volume":"41","author":"E Schiffer","year":"2005","unstructured":"Schiffer E, Housset C, Cacheux W, Wendum D, Desbois-Mouthon C, Rey C, Clergue F, Poupon R, Barbu V, Rosmorduc O (2005) Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis. Hepatology 41(2):307\u2013314. https:\/\/doi.org\/10.1002\/hep.20538","journal-title":"Hepatology"},{"issue":"3","key":"4999_CR44","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S2221-1691(11)60026-9","volume":"1","author":"M Sengupta","year":"2011","unstructured":"Sengupta M, Sharma GD, Chakraborty B (2011) Hepatoprotective and immunomodulatory properties of aqueous extract of Curcuma longa in carbon tetra chloride intoxicated Swiss albino mice. Asian Pac J Trop Biomed 1(3):193\u2013199. https:\/\/doi.org\/10.1016\/S2221-1691(11)60026-9","journal-title":"Asian Pac J Trop Biomed"},{"issue":"12","key":"4999_CR45","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1369\/0022155413503662","volume":"61","author":"B Shi","year":"2013","unstructured":"Shi B, Abrams M, Sepp-Lorenzino L (2013) Expression of asialoglycoprotein receptor 1 in human hepatocellular carcinoma. J Histochem Cytochem 61(12):901\u2013909. https:\/\/doi.org\/10.1369\/0022155413503662","journal-title":"J Histochem Cytochem"},{"key":"4999_CR46","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cbi.2017.12.007","volume":"280","author":"AK Singh","year":"2018","unstructured":"Singh AK, Raj V, Keshari AK, Rai A, Kumar P, Rawat A, Maity B, Kumar D, Prakash A, De A, Samanta A, Bhattacharya B, Saha S (2018) Isolated mangiferin and naringenin exert antidiabetic effect via PPAR(\u03b3)\/GLUT4 dual agonistic action with strong metabolic regulation. Chem Biol Interact 280:33\u201344. https:\/\/doi.org\/10.1016\/j.cbi.2017.12.007","journal-title":"Chem Biol Interact"},{"key":"4999_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.101920","volume":"43","author":"D Singh","year":"2024","unstructured":"Singh D, Khan MA, Mishra D, Goel A, Ansari MA, Akhtar K, Siddique HR (2024) Apigenin enhances sorafenib anti-tumour efficacy in hepatocellular carcinoma. Transl Oncol 43:101920. https:\/\/doi.org\/10.1016\/j.tranon.2024.101920","journal-title":"Transl Oncol"},{"issue":"4","key":"4999_CR48","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.3109\/10717544.2016.1162878","volume":"23","author":"Singh RP Sonali","year":"2016","unstructured":"Sonali Singh RP, Singh N, Sharma G, Vijayakumar MR, Koch B, Singh S, Singh U, Dash D, Pandey BL, Muthu MS (2016) Transferrin liposomes of docetaxel for brain-targeted cancer applications: formulation and brain theranostics. Drug Deliv 23(4):1261\u20131271. https:\/\/doi.org\/10.3109\/10717544.2016.1162878","journal-title":"Drug Deliv"},{"issue":"1","key":"4999_CR49","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1053\/jhep.2001.25387","volume":"34","author":"T Takehara","year":"2001","unstructured":"Takehara T, Liu X, Fujimoto J, Friedman SL, Takahashi H (2001) Expression and role of Bcl-xL in human hepatocellular carcinomas. Hepatology 34(1):55\u201361. https:\/\/doi.org\/10.1053\/jhep.2001.25387","journal-title":"Hepatology"},{"key":"4999_CR50","doi-asserted-by":"publisher","unstructured":"Van Der Steen N, Giovannetti E, Carbone D, Leonetti A, Rolfo C, Peters G (2018) Resistance to epidermal growth factor receptor inhibition in non-small cell lung cancer. Cancer Drug Resistance 1. https:\/\/doi.org\/10.20517\/cdr.2018.13","DOI":"10.20517\/cdr.2018.13"},{"key":"4999_CR51","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jddst.2016.02.009","volume":"33","author":"MR Vijayakumar","year":"2016","unstructured":"Vijayakumar MR, Kosuru R, Vuddanda PR, Singh SK, Singh S (2016) Trans resveratrol loaded DSPE PEG 2000 coated liposomes: an evidence for prolonged systemic circulation and passive brain targeting. J Drug Deliv Sci Technol 33:125\u2013135. https:\/\/doi.org\/10.1016\/j.jddst.2016.02.009","journal-title":"J Drug Deliv Sci Technol"},{"issue":"3","key":"4999_CR52","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3892\/ijo.21.3.515","volume":"21","author":"J Watanabe","year":"2002","unstructured":"Watanabe J, Kushihata F, Honda K, Mominoki K, Matsuda S, Kobayashi N (2002) Bcl-xL overexpression in human hepatocellular carcinoma. Int J Oncol 21(3):515\u2013519. https:\/\/doi.org\/10.3892\/ijo.21.3.515","journal-title":"Int J Oncol"},{"issue":"3","key":"4999_CR53","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ejps.2012.02.007","volume":"46","author":"M Wei","year":"2012","unstructured":"Wei M, Xu Y, Zou Q, Tu L, Tang C, Xu T, Deng L, Wu C (2012) Hepatocellular carcinoma targeting effect of PEGylated liposomes modified with lactoferrin. Eur J Pharm Sci 46(3):131\u2013141. https:\/\/doi.org\/10.1016\/j.ejps.2012.02.007","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"4999_CR54","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ymthe.2017.08.019","volume":"26","author":"JLS Willoughby","year":"2018","unstructured":"Willoughby JLS, Chan A, Sehgal A, Butler JS, Nair JK, Racie T, Shulga-Morskaya S, Nguyen T, Qian K, Yucius K, Charisse K, van Berkel TJC, Manoharan M, Rajeev KG, Maier MA, Jadhav V, Zimmermann TS (2018) Evaluation of GalNAc-siRNA conjugate activity in pre-clinical animal models with reduced asialoglycoprotein receptor expression. Mol Ther 26(1):105\u2013114. https:\/\/doi.org\/10.1016\/j.ymthe.2017.08.019","journal-title":"Mol Ther"},{"key":"4999_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.715824","author":"S Xi","year":"2021","unstructured":"Xi S, Zhai X, Wang Y, Gong Y, Fu B, Gao C, Guo X, Li Y, Wang Z, Huang S, Lu D, Zhao Y, Qian L, Wang Y (2021) The Ciji-Hua\u2019ai-Baosheng II formula attenuates chemotherapy-induced anorexia in mice with H22 hepatocellular carcinoma. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2021.715824","journal-title":"Front Pharmacol"},{"key":"4999_CR56","first-page":"283","volume":"7","author":"R Yadav","year":"2015","unstructured":"Yadav R, Keshari A, Singh A, Saha S (2015) Antidiabetic and hypolipidemic effect of ficus racemosa petroleum ether extract in streptozotocin induced diabetic albino rats. Int J Pharm Pharm Sci 7:283\u2013287","journal-title":"Int J Pharm Pharm Sci"},{"issue":"9","key":"4999_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-1884-7","volume":"10","author":"F Yin","year":"2019","unstructured":"Yin F, Feng F, Wang L, Wang X, Li Z, Cao Y (2019) SREBP-1 inhibitor Betulin enhances the antitumor effect of Sorafenib on hepatocellular carcinoma via restricting cellular glycolytic activity. Cell Death Dis 10(9):672. https:\/\/doi.org\/10.1038\/s41419-019-1884-7","journal-title":"Cell Death Dis"},{"issue":"11","key":"4999_CR58","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/nrc2734","volume":"9","author":"H Yu","year":"2009","unstructured":"Yu H, Pardoll D, Jove R (2009) STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 9(11):798\u2013809. https:\/\/doi.org\/10.1038\/nrc2734","journal-title":"Nat Rev Cancer"},{"key":"4999_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2022.107423","volume":"167","author":"H Zhang","year":"2022","unstructured":"Zhang H, Lu L, Zhao C, Liu Q, Zhou Q, Zhang Y, Pu Y, Wang S, Liu R, Yin L (2022) Lipid metabolism disorders contribute to hepatotoxicity of ICR mice induced by nitrosamines exposure. Environ Int 167:107423. https:\/\/doi.org\/10.1016\/j.envint.2022.107423","journal-title":"Environ Int"},{"issue":"1","key":"4999_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-02075-w","volume":"10","author":"J Zheng","year":"2025","unstructured":"Zheng J, Wang S, Xia L, Sun Z, Chan KM, Bernards R, Qin W, Chen J, Xia Q, Jin H (2025) Hepatocellular carcinoma: signaling pathways and therapeutic advances. Signal Transduct Target Ther 10(1):35. https:\/\/doi.org\/10.1038\/s41392-024-02075-w","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"4999_CR61","first-page":"2919","volume":"32","author":"X Zhou","year":"2012","unstructured":"Zhou X, Yung B, Huang Y, Li H, Hu X, Xiang G, Lee RJ (2012) Novel liposomal gefitinib (L-GEF) formulations. Anticancer Res 32(7):2919\u20132923","journal-title":"Anticancer Res"},{"issue":"1","key":"4999_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/s12575-025-00281-6","volume":"27","author":"Y Zou","year":"2025","unstructured":"Zou Y, Wan X, Zhou Q, Zhu G, Lin S, Tang Q, Yang X, Wang S (2025) Mechanisms of drug resistance in hepatocellular carcinoma. Biol Proced Online 27(1):19. https:\/\/doi.org\/10.1186\/s12575-025-00281-6","journal-title":"Biol Proced Online"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-04999-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-04999-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-04999-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T02:55:46Z","timestamp":1782096946000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-04999-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":62,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["4999"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-04999-2","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"9 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol was approved by the Institutional Animal Ethics Committee of MET Faculty of Pharmacy for animal experimentation (METFOP\/IAEC\/01\/25).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial"}}]}}